For citations:
. EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION. Rational Pharmacotherapy in Cardiology. 2014;10(3):360. (In Russ.)
Views: 143
Fullscreen
Popular articles
Vol 11, No 3 (2015)
Vol 14, No 5 (2018)
Vol 6, No 2 (2010)
Vol 13, No 5 (2017)
Vol 17, No 5 (2021)
Editor-in-Chief
Drapkina O. M.
Article Tools
Email this article (Login required)
Email the author (Login required)
Email this article (Login required)
Email the author (Login required)
About the Author
Keywords
acute coronary syndrome
amlodipine
apixaban
arterial hypertension
atherosclerosis
atrial fibrillation
cardiovascular diseases
cardiovascular risk
chronic heart failure
dabigatran
heart failure
hypertension
ischemic heart disease
metabolic syndrome
myocardial infarction
obesity
risk factors
rivaroxaban
statins
stroke
warfarin
Moscow 101990, Russia
Petroverigsky per. 10
Tel.: +7 (499) 553 68 10
е-mail: otsec@sticom.ru
